Sale!

Acute Leukemia Panel Test

2,800 د.إ

-22%

The Acute Leukemia Panel Test is a sophisticated diagnostic procedure designed to identify and classify acute leukemia, a rapid-onset cancer affecting the blood and bone marrow. This test is crucial for determining the specific type of leukemia, which can significantly influence treatment decisions and prognosis. By analyzing genetic markers and abnormalities associated with leukemia, the panel provides comprehensive insights that are vital for tailoring patient-specific therapeutic approaches.

Conducted at DNA Labs UAE, a leading facility known for its state-of-the-art technology and expert medical professionals, the test ensures accuracy and reliability. The cost of the Acute Leukemia Panel Test is 2800 AED, reflecting the intricate analysis and detailed information it provides. This investment can be invaluable for patients and healthcare providers alike, offering a foundation for targeted treatment plans and improved outcomes in the battle against acute leukemia.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

Acute Leukemia Panel Test

Test Name: Acute Leukemia Panel Test

Components: EDTA Vacutainer (2ml)/Sodium heparin

Price: 2800.0 AED

Sample Condition: Bone Marrow / Peripheral blood

Report Delivery: 1-2 days

Method: Flowcytometry

Test type: Genetics

Doctor: General Surgeon

Test Department:

Pre Test Information

Acute Leukemia Panel can be done with a doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

The Acute Leukemia Panel is a diagnostic test used to determine the specific type of acute leukemia a patient may have. It typically includes a combination of laboratory tests and genetic analysis.

The panel may include the following tests:

  1. Complete blood count (CBC): This test measures the number of red blood cells, white blood cells, and platelets in the blood. Abnormal counts can indicate leukemia.
  2. Blood smear: A sample of blood is examined under a microscope to look for abnormal cells, such as blast cells, which are immature white blood cells often seen in leukemia.
  3. Bone marrow aspiration and biopsy: A small sample of bone marrow is taken and examined under a microscope to determine the percentage of blast cells present. This helps to confirm the diagnosis of leukemia.
  4. Flow cytometry: This test uses fluorescently-labeled antibodies to identify specific proteins on the surface of cells. It helps determine the type of leukemia by analyzing the markers present on the blast cells.
  5. Cytogenetic analysis: This test examines the chromosomes of the leukemia cells to identify any specific genetic abnormalities, such as translocations or deletions. These abnormalities can help guide treatment decisions and provide prognostic information.
  6. Molecular genetic testing: This test looks for specific genetic mutations or rearrangements in the leukemia cells. Examples include testing for mutations in genes like FLT3, NPM1, or DNMT3A. These mutations can also guide treatment decisions and provide prognostic information.

The results of the Acute Leukemia Panel help doctors determine the specific subtype of acute leukemia a patient has, which is important for determining the most appropriate treatment plan.

Test Name Acute Leukemia Panel Test
Components EDTA Vacutainer (2ml)/Sodium heparin
Price 2800.0 AED
Sample Condition Bone Marrow \/ Peripheral blood
Report Delivery 1-2 days
Method Flowcytometry
Test type Genetics
Doctor General Surgeon
Test Department:
Pre Test Information Acute Leukemia Panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

The Acute Leukemia Panel is a diagnostic test used to determine the specific type of acute leukemia a patient may have. It typically includes a combination of laboratory tests and genetic analysis.

The panel may include the following tests:

1. Complete blood count (CBC): This test measures the number of red blood cells, white blood cells, and platelets in the blood. Abnormal counts can indicate leukemia.

2. Blood smear: A sample of blood is examined under a microscope to look for abnormal cells, such as blast cells, which are immature white blood cells often seen in leukemia.

3. Bone marrow aspiration and biopsy: A small sample of bone marrow is taken and examined under a microscope to determine the percentage of blast cells present. This helps to confirm the diagnosis of leukemia.

4. Flow cytometry: This test uses fluorescently-labeled antibodies to identify specific proteins on the surface of cells. It helps determine the type of leukemia by analyzing the markers present on the blast cells.

5. Cytogenetic analysis: This test examines the chromosomes of the leukemia cells to identify any specific genetic abnormalities, such as translocations or deletions. These abnormalities can help guide treatment decisions and provide prognostic information.

6. Molecular genetic testing: This test looks for specific genetic mutations or rearrangements in the leukemia cells. Examples include testing for mutations in genes like FLT3, NPM1, or DNMT3A. These mutations can also guide treatment decisions and provide prognostic information.

The results of the Acute Leukemia Panel help doctors determine the specific subtype of acute leukemia a patient has, which is important for determining the most appropriate treatment plan.